MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics for Hydrocephalus and Alzheimer's Disease
This study is testing a special type of MRI (Magnetic Resonance Imaging) to measure how cerebrospinal fluid (CSF), the fluid around your brain, moves. Researchers want to see if this MR imaging method can help diagnose and better understand conditions like hydrocephalus and Alzheimer's disease, which affect brain function. They will compare CSF movement in healthy adults to those with these conditions. You would have an MRI scan and potentially a urine pregnancy test if you are a pre-menopausal female. The main goal is to see if this MRI method can accurately measure CSF flow. The study is currently unclear on its recruitment status and plans to enroll 50 participants.
- Study design
- This interventional study plans to enroll 50 participants, comparing healthy individuals with those who have conditions affecting brain function.
- What's involved
- You would complete an MRI screening form, potentially a urine pregnancy test, and undergo an MR brain scan lasting about one hour.
- Compensation
- Not stated in the trial record.
- Follow-up
- CSF flow will be measured at the time of the MR exam, which is approximately one hour.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Petrice Cogswell, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- CSF flow measurementAt the time of MR exam, approximately one hour
CSF flow will be measured in participants and compared between those with unimpaired brain function and those with clinical diagnosis of a disease that affects brain function, such as Alzheimer's disease and normal pressure hydrocephalus.